Telix Pharmaceuticals Limited (TLX) Shareholder Equity
- 2025-12-31: Retained EarningsAUD (m); Retained EarningsUSD $-154.54M.
- 2024-12-31: Retained EarningsAUD -212.96M; Retained EarningsUSD $-152.91M.
- 2023-12-31: Retained EarningsAUD -263.67M; Retained EarningsUSD $-187.12M.
Telix Pharmaceuticals Limited Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Retained Earnings AUD | Retained Earnings USD |
|---|---|---|
| 2025-12-31 | (m) | $-154.54M |
| 2024-12-31 | -212.96M | $-152.91M |
| 2023-12-31 | -263.67M | $-187.12M |